Surrey Heartlands

Joint Formulary & PAD

Digoxin - Arrhythmias

You are here : Home > Formulary Search > Digoxin - Arrhythmias

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Elixir
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
ONE 62.5mcg tablet is equivalent to 50mcg (1ml) of elixir
 

Status 2

Red
Formulations :
  • Injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :

Documentation

Guidelines (Local)
Atrial Fibrillation Management - Secondary Care Pathway - February 2018
Guidelines (Local)
Atrial Fibrillation Management -Primary Care Pathway - February 2018

PAD Profile

ChemicalSubstance :
Digoxin
Indication :
Arrhythmias
Group Name :
Keywords :
atrial fibrillation, atrial flutter, cardiac glycosides
Brand Names Include :
Lanoxin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Digoxin is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Arrhythmias.

Committee Recommendations (2)

06 Dec 17 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Updated Kent Surrey & Sussex Academic Health Science Network (KSS AHSN) Atrial Fibrillation pathways attached for information (See below)
01 Jul 15 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
This drug has been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status.